Atlas Trials

FEnofibRate as a Metabolic INtervention for COVID-19

Clinical trial NCT04517396 · COMPLETED

Trial details

NCT number
NCT04517396
Sponsor
University of Pennsylvania
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19
Start date
2020-08-18
Primary completion
2022-03-30
Enrollment
701

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.